Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Exchange Rate Effect (2020 - 2025)

RxSight (RXST) has disclosed Exchange Rate Effect for 6 consecutive years, with -$15000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 25.0% year-over-year to -$15000.0, compared with a TTM value of $3000.0 through Dec 2025, up 133.33%, and an annual FY2025 reading of $3000.0, up 133.33% over the prior year.
  • Exchange Rate Effect was -$15000.0 for Q4 2025 at RxSight, down from -$2000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $14000.0 in Q4 2022 and bottomed at -$15000.0 in Q4 2025.
  • Average Exchange Rate Effect over 5 years is -$950.0, with a median of -$2500.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect crashed 1000.0% in 2022, then surged 1500.0% in 2025.
  • Year by year, Exchange Rate Effect stood at -$3000.0 in 2021, then skyrocketed by 566.67% to $14000.0 in 2022, then crashed by 42.86% to $8000.0 in 2023, then tumbled by 250.0% to -$12000.0 in 2024, then fell by 25.0% to -$15000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for RXST at -$15000.0 in Q4 2025, -$2000.0 in Q3 2025, and $14000.0 in Q2 2025.